Derren Nathan Of Hybridan Takes A Detailed Look At Sareum Holdings Who Is Investigating Small Molecule In The Treatment Of Auto-Immune Disease, Cancer, And With The Award Of A Recent NIHR Grant, Severe Phase Covid-19.
